Goldman Sachs suspended the firm’s rating on Bright Health Group citing "insufficient information" following the Q4 report. Bright Health disclosed that a "going concern" qualification will be added to its annual filing concerning its ability to fund operations over the next 12 months, the analyst tells investors in a research note. The company unrestricted cash and cash equivalents of $150M, as of February 24, below the minimum level of $200M required under its fully-drawn credit facility, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BHG:
